Abstract
It is of particular concern to evaluate the risk of lung cancer occurrence after breast cancer treatment as women with breast cancer quite often undergo radiation therapy as part of their initial treatment and their life expectancy remains long. From a roster of 7711 women initially treated for breast cancer between 1954 and 1984, a cohort-study was performed among 4171 1-year survivors followed during the period 1975–1995. The relationship between the radiation dose received by the lung and the risk of lung cancer was then evaluated in a nested case-control study of 11 breast-cancer patients who developed lung cancer and 22 controls matched for age at diagnosis of breast cancer, period of initial treatment and length of follow-up. Among the 4171 women, six developed lung cancer during the entire follow-up as compared to 5.4 cases expected (SIR = 1.1, 95%CI: 0.4–2.3). When considering only the women initially treated by radiotherapy with or without adjunction of chemotherapy and excluding the 10 first years of follow-up, the SIR was significantly increased (SIR = 3.2, 95%CI: 1.0–7.4). In the case-control study, nine of the 11 lung cancers occurred in the ipsilateral lung and two in the trachea. The overall odds ratio (OR) of lung cancer associated with initial radiotherapy was 1.4 (95%CI: 0.2–11.1) and an excess in the OR of 7% (90%CI: ? to 41%, p = 0.10) per gray delivered to the site of lung cancer was evidenced. Our results agree with previous studies in favor of an increased risk of lung cancer after radiation therapy for breast cancer.
Similar content being viewed by others
References
Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL: Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958–1987. Radiat Res 137: S17–S67, 1994
UNSCEAR: Sources and Effects of Ionizing Radiation. United Nations, New-York, N.Y., USA, 2000
Griem ML, Kleinerman RA, Boice JD, Stovall M, Shefner D, Lubin JH: Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 86: 842–849, 1994
van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, Belt-Dusebout AW, Noyon R, Boice JD, Burgers JM, Somers R: Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87: 1530–1537, 1995
Weiss HA, Darby SC, Doll R: Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 59: 327–338, 1994
Darby SC, Reeves G, Key T, Doll R, Stovall M: Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 56: 793–801, 1994
Howe GR: Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res 142: 295–304, 1995
Ron E, Boice JD, Hamburger S, Stovall M: Mortality following radiation treatment for infertility of hormonal origin or amenorrhoea. Int J Epidemiol 23: 1165–1173, 1994
Inskip PD, Stovall M, Flannery JT: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 86: 983–988, 1994
Menegoz F, Cherié-Challine L: Le Cancer en France: Incidence et Mortalité. Situation en 1995. Evolution entre 1975 et 1995. Reseau FRANCIM, 2000
Sarrazin D, Le MG, Mouriesse H, Contesso G, Fontaine F, Arriagada R, Tubiana M: Radiotherapeutic studies on breast cancer at Villejuif. Cancer Bull 34: 242–249, 1982
Sarrazin D, Le MG, Rouesse J, Contesso G, Petit JY, Lacour J, Viguier J, Hill C: Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer 53: 1209–1213, 1984
Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Le MG: Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 61: 183–195, 2000
Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J: Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 38: 269–271, 1996
Grimaud E, Shamsaldin A, Lamon A: Programme original de calcul de dose applique a l'étude de seconds cancers, sfro 5éme Congrés, Paris, France. Bull Cancer/Radiother 81: 482, 1994
Shamsaldin A, Grimaud E, Diallo I, Hardiman C, de Vathaire F, Chavaudra J: Knowledge of doses from external radiotherapy for a cancer in childhood. IAEA Tech Doc 976: 94–97, 1997
Shamsaldin A, Grimaud E, Hardiman C, Diallo I, de Vathaire F, Chavaudra J: Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood. Radiother Oncol 49: 85–90, 1998
Shamsaldin A, Grimaud E, Ligot L, Diallo I, de Vathaire F, Chavaudra J: Theoretical Models for Retrospective Dosimetry, IRPA10, Japon., Proceedings p-3a-208: 1–6, 2000
Benhamou E, Laplanche A, Wartelle M, Faivre J, Gignoux M, Robillard J, Schraub S, Flamant R: Incidence des cancers en France 1978–1982. Les éditions INSERM, Paris, France. Paris: Les Editions de l'INSERM, 1990
de Vathaire F, Koscielny S, Rezvani A, Laplanche A, Estève J, Ferlay J: Estimation de l'incidence des cancers en France: période 1983–1987. Les Editions INSERM, Paris, France. Paris: Les Editions de l'INSERM, 1996
Breslow NE, Day NE: Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ 1–406, 1987
Preston DL, Lubin JH, Pierce DA, McConney ME: EPICURE. Generalized Regression Models for Epidemiological Data. Hirosoft International Corporation, Seattle, 1991
Moolgavkar SH, Venzon DJ: A method for computing profile likelihood-based confidence bounds. Ann Statist 15: 346–359, 1987
Adami HO, Bergkvist L, Krusemo U, Persson I: Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study. J Natl Cancer Inst 73: 1049–1055, 1984
Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV: Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 84: 435–440, 2001.
Doherty MA, Rodger A, Langlands AO, Kerr GR: Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol 26: 125–131, 1993
Ewertz M, Mouridsen HT: Second cancer following cancer of the female breast in Denmark, 1943–80. Natl Cancer Inst Monogr 68: 325–329, 1985
Hankey BF, Miller B, Curtis R, Kosary C: Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 7–14, 1994
Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr 68: 99–112, 1985
Lavey RS, Eby NL, Prosnitz LR: Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 66: 874–881, 1990
Murakami R, Hiyama T, Hanai A, Fujimoto I: Second primary cancers following female breast cancer in Osaka, Japan–a population-based cohort study. Jpn J Clin Oncol 17: 293–302, 1987
Schottenfeld D, Berg J: Incidence of miltiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 46: 161–170, 1971
Schwartz AG, Ragheb NE, Swanson GM, Satariano WA: Racial and age differences in multiple primary cancers after breast cancer: a population-based analysis. Breast Cancer Res Treat 14: 245–254, 1989
Teppo L, Pukkala E, Saxen E: Multiple cancer–an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207–217, 1985
Travis LB, Curtis RE, Inskip PD, Hankey BF: Re: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 87: 60–61, 1995
Valagussa P, Moliterni A, Terenziani M, Zambetti M, Bonadonna G: Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 5: 803–808, 1994
Volk N, Pompe-Kirn V: Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Cont 8: 764–770, 1997
Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF, Boice JD, Gilbert E: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94: 182–192, 2002
Neugut AI, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ: Lung cancer after radiation therapy for breast cancer. Cancer 71: 3054–3057, 1993
Davis FG, Boice JD, Hrubec Z, Monson RR: Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 49: 6130–6136, 1989
Neugut AI, Murray T, Santos J, Amols H, Hayes MK, Flannery JT, Robinson E: Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73: 1615–1620, 1994
Pershagen G, Akerblom G, Axelson O, Clavensjo B, Damber L, Desai G, Enflo A, Lagarde F, Mellander H, Svartengren M, Swedjemark GA: Residential radon exposure and lung cancer in Sweden. N Engl J Med 330: 159–164, 1994
Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR: Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52: 406–414, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubino, C., de Vathaire, F., Diallo, I. et al. Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment. Breast Cancer Res Treat 75, 15–24 (2002). https://doi.org/10.1023/A:1016590315382
Issue Date:
DOI: https://doi.org/10.1023/A:1016590315382